Log in to save to my catalogue

Glyoxal in hyperglycaemic ischemic stroke – a cohort study

Glyoxal in hyperglycaemic ischemic stroke – a cohort study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_059cd2a8279e4ad29ee5c62318e45b7c

Glyoxal in hyperglycaemic ischemic stroke – a cohort study

About this item

Full title

Glyoxal in hyperglycaemic ischemic stroke – a cohort study

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2023-07, Vol.22 (1), p.173-173, Article 173

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Hyperglycaemia is frequent in acute ischemic stroke and denotes a bad prognosis, even in the absence of pre-existing diabetes. However, in clinical trials treatment of elevated glucose levels with insulin did not improve stroke outcome, suggesting that collateral effects rather than hyperglycaemia itself aggravate ischemic brain damage. As reactive...

Alternative Titles

Full title

Glyoxal in hyperglycaemic ischemic stroke – a cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_059cd2a8279e4ad29ee5c62318e45b7c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_059cd2a8279e4ad29ee5c62318e45b7c

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-023-01892-7

How to access this item